Semaglutide Misuse Under Watch: Telangana DCA Issues Advisory After Generic Launch Surge
New Delhi: In response to the growing demand and widespread use of Semaglutide formulations following the patent expiry of innovator products in March 2026, the Drugs Control Administration (DCA), Telangana,…